Feeds

Aussie nano tech project gets AU$15m in global VC funding

Needle-free drug patches set to go commercial

  • alert
  • submit to reddit

Choosing a cloud hosting partner with confidence

A Queensland-based nanotech start-up has secured AU$15m in funding from a group of international biotechnology investors.

Venture capital firm One Venture is backing the creation of start-up vehicle Vaxxas, which will allow the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) Professor Mark Kendall to work towards commercialising his patented Nanopatch technology,

The technology delivers vaccines to immune cells in the skin, instead of using a syringe method, which injects into the muscle. The Nanopatch, which is smaller than the size of a postage stamp and has the potential to be self-applied, was first conceived in 2003.

Co-investors in the new vehicle include US-based HealthCare Ventures, Brandon Capital, and the Medial Research Commercialisation Fund.

The University of Queensland’s main commercialisation company, UniQuest, has led the commercialisation of the Nanopatch technology to date, and will hand over the responsibility to Vaxxas following this investment.

Brandon Capital Partners Managing Director Dr Stephen Thompson says launching Vaxxas as a company is a critical next step for the Nanopatch technology.

“In Australia, we invest heavily in our excellent research and development capability but have a relatively poor record of taking those technologies to world markets,” he said.

In addition to improving the efficiency of delivery, the Nanopatch does not require refrigeration, making transport much cheaper and easier, particularly to developing nations around the world. ®

Top 5 reasons to deploy VMware with Tegile

More from The Register

next story
Bond villains lament as Wicked Lasers withdraw death ray
Want to arm that shark? Better get in there quick
Renewable energy 'simply WON'T WORK': Top Google engineers
Windmills, solar, tidal - all a 'false hope', say Stanford PhDs
The next big thing in medical science: POO TRANSPLANTS
Your brother's gonna die, kid, unless we can give him your, well ...
SEX BEAST SEALS may be egging each other on to ATTACK PENGUINS
Boffin: 'I think the behaviour is increasing in frequency'
NASA launches new climate model at SC14
75 days of supercomputing later ...
Britain's HUMAN DNA-strewing Moon mission rakes in £200k
3 days, and Kickstarter moves lander 37% nearer takeoff
Reuse the Force, Luke: SpaceX's Elon Musk reveals X-WING designs
And a floating carrier for recyclable rockets
Simon's says quantum computing will work
Boffins blast algorithm with half a dozen qubits
prev story

Whitepapers

Why cloud backup?
Combining the latest advancements in disk-based backup with secure, integrated, cloud technologies offer organizations fast and assured recovery of their critical enterprise data.
A strategic approach to identity relationship management
ForgeRock commissioned Forrester to evaluate companies’ IAM practices and requirements when it comes to customer-facing scenarios versus employee-facing ones.
5 critical considerations for enterprise cloud backup
Key considerations when evaluating cloud backup solutions to ensure adequate protection security and availability of enterprise data.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
Choosing a cloud hosting partner with confidence
Download Choosing a Cloud Hosting Provider with Confidence to learn more about cloud computing - the new opportunities and new security challenges.